查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1285860

C反应蛋白检测市场 - 2023-2031年全球行业分析、规模、份额、增长、趋势和预测

C-reactive Protein Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 194 Pages | 商品交期: 2-10个工作天内

价格

C-反应蛋白检测市场 - 报告范围

TMR关于全球C-反应蛋白测试市场的报告研究了过去以及当前的增长趋势和机会，以获得对2023年至2031年预测期间市场指标的宝贵见解。报告提供了2017-2031年期间全球C-反应蛋白检测市场的收入，考虑到2023年为基准年，2031年为预测年。报告还提供了2023年至2031年全球C-反应蛋白检测市场的复合年增长率（CAGR %）。

该报告是在广泛研究后编写的。一级研究涉及大部分的研究工作，其中分析师与关键意见领袖、行业领袖和意见制造者进行了访谈。二级研究包括参考主要参与者的产品资料、年度报告、新闻稿和相关文件，以了解等离子体材料市场。

该报告深入研究了全球等离子体材料市场的竞争格局。在全球C-反应蛋白测试市场运作的主要参与者已被确定，其中每一个都在各种属性方面进行了分析。公司概况、财务状况、近期发展和SWOT是本报告对全球C-反应蛋白检测市场参与者的属性描述。

目录

第一章：前言

  • 市场定义和范围
  • 市场细分
  • 主要研究目标
  • 研究重点

第二章：假设和研究方法

第三章：执行摘要：全球市场

第四章：市场概述

  • 简介
    • 细分市场的定义
    • 行业演变/发展
  • 市场概况
  • 市场动态
    • 驱动力
    • 限制因素
    • 机会
  • 2017-2031年全球市场分析与预测

第五章：关键洞察力

  • 市场概况
  • 主要产品/品牌分析
  • 管线分析
  • COVID-19大流行对行业的影响

第六章：全球市场分析与预测：按测试类型分类

  • 介绍和定义
  • 主要发现/发展
  • 市场价值预测：按测试类型，2017-2031年
    • 标准C反应蛋白测试
    • 高敏C反应蛋白（hs-CRP）测试
  • 市场吸引力分析：按测试类型

第七章 ：全球市场分析和预测：按检测类型分类

  • 介绍和定义
  • 主要研究结果/发展
  • 市场价值预测：按检测类型，2017-2031年
    • 酶联免疫法
    • 免疫比浊法
    • 免疫层析法
    • 免疫荧光法
    • 其他检测方法
  • 市场吸引力分析：按检测类型分类

第八章：全球市场分析与预测：按适应症分类

  • 介绍和定义
  • 主要研究结果/发展
  • 市场价值预测：按适应症分类，2017-2031年
    • 心脏病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市场吸引力分析：按适应症分类

第九章：全球市场分析与预测：按终端用户分类

  • 介绍和定义
  • 主要研究结果/发展
  • 市场价值预测：按终端用户，2017-2031年
    • 医院联合实验室
    • 独立诊断实验室
    • 其他
  • 市场吸引力分析：按终端用户分类

第十章：全球市场分析与预测：按地区划分

  • 主要发现
  • 市场价值预测：按地区，2017-2031年
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第11章 ：北美洲市场分析与预测

  • 简介
    • 主要发现
  • 市场价值预测：按测试类型，2017-2031年
    • 标准C反应蛋白测试
    • 高敏C反应蛋白（hs-CRP）测试
  • 市场价值预测：按化验类型，2017-2031年
    • 酶联免疫法
    • 免疫比浊法
    • 免疫层析法
    • 免疫荧光法
    • 其他
  • 市场价值预测：2017-2031年，按适应症分类
    • 心脏病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市场价值预测：按终端用户，2017-2031年
    • 医院联合实验室
    • 独立诊断实验室
    • 其他
  • 市场价值预测：按国家划分，2017-2031年
    • 美国
    • 加拿大
  • 市场吸引力分析
    • 按测试类型
    • 按化验类型
    • 按适应症分类
    • 按终端用户分类
    • 按国家分类

第12章 ：欧洲市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按测试类型，2017-2031年
    • 标准C反应蛋白测试
    • 高敏C反应蛋白（hs-CRP）测试
  • 市场价值预测：按化验类型，2017-2031年
    • 酶联免疫法
    • 免疫比浊法
    • 免疫层析法
    • 免疫荧光法
    • 其他
  • 市场价值预测：2017-2031年，按适应症分类
    • 心脏病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市场价值预测：按终端用户，2017-2031年
    • 医院联合实验室
    • 独立诊断实验室
    • 其他
  • 市场价值预测：按国家/次区域划分，2017-2031年
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 市场吸引力分析
    • 按测试类型
    • 按化验类型
    • 按适应症分类
    • 按终端用户
    • 按国家/次区域分类

第13章 ：亚太地区市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按测试类型，2017-2031年
    • 标准C反应蛋白测试
    • 高敏C反应蛋白（hs-CRP）测试
  • 市场价值预测：按化验类型，2017-2031年
    • 酶联免疫法
    • 免疫比浊法
    • 免疫层析法
    • 免疫荧光法
    • 其他
  • 市场价值预测：2017-2031年，按适应症分类
    • 心脏病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市场价值预测：按终端用户，2017-2031年
    • 医院联合实验室
    • 独立诊断实验室
    • 其他
  • 市场价值预测：按国家/次区域划分，2017-2031年
    • 中国
    • 日本
    • 印度
    • 澳大利亚和新西兰
    • 亚太其他地区
  • 市场吸引力分析
    • 按测试类型
    • 按检测类型
    • 按适应症分类
    • 按终端用户
    • 按国家/次区域分类

第十四章 ：拉美市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按测试类型，2017-2031年
    • 标准C反应蛋白测试
    • 高敏C反应蛋白（hs-CRP）测试
  • 市场价值预测：按化验类型，2017-2031年
    • 酶联免疫法
    • 免疫比浊法
    • 免疫层析法
    • 免疫荧光法
    • 其他
  • 市场价值预测：2017-2031年，按适应症分类
    • 心脏病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市场价值预测：按终端用户，2017-2031年
    • 医院联合实验室
    • 独立诊断实验室
    • 其他
  • 市场价值预测：按国家/次区域划分，2017-2031年
    • 巴西
    • 墨西哥
    • 拉美其他地区
  • 市场吸引力分析
    • 按测试类型
    • 按检测类型
    • 按适应症分类
    • 按终端用户
    • 按国家/次区域分类

第15章 ：中东和非洲市场分析和预测

  • 简介
    • 主要发现
  • 市场价值预测：按测试类型，2017-2031年
    • 标准C反应蛋白测试
    • 高敏C反应蛋白（hs-CRP）测试
  • 市场价值预测：按化验类型，2017-2031年
    • 酶联免疫法
    • 免疫比浊法
    • 免疫层析法
    • 免疫荧光法
    • 其他
  • 市场价值预测：2017-2031年，按适应症分类
    • 心脏病
    • 炎症性疾病
    • 感染性疾病
    • 其他疾病
  • 市场价值预测：按终端用户，2017-2031年
    • 医院联合实验室
    • 独立诊断实验室
    • 其他
  • 市场价值预测：按国家/次区域划分，2017-2031年
    • 海湾合作委员会国家
    • 南非
    • 中东和非洲其他地区
  • 市场吸引力分析
    • 按测试类型
    • 按检测类型
    • 按适应症分类
    • 按终端用户
    • 按国家/次区域分类

第16章 ：竞争格局

  • 市场参与者 - 竞争矩阵（按公司层级和规模）。
  • 市场份额分析：按公司分类 (2022)
  • 公司简介
    • Agilent Technologies, Inc.
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Creative Diagnostics
    • DxGen Corp
    • CTK Biotech, Inc.
    • Getein Biotech, Inc.
    • Goldsite Diagnostics, Inc.
    • OptiBio Co., Ltd.
    • Nanjing Vazyme Biotech Co., Ltd.
Product Code: TMRGL1899

C-Reactive Protein Testing Market - Scope of Report

TMR's report on the global C-Reactive Protein Testing Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global C-Reactive Protein Testing Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global C-Reactive Protein Testing Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the C-Reactive Protein Testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global C-Reactive Protein Testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global C-Reactive Protein Testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global C-Reactive Protein Testing market.

The report delves into the competitive landscape of the global C-Reactive Protein Testing market. Key players operating in the global C-Reactive Protein Testing Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global C-Reactive Protein Testing Market profiled in this report.

Key Questions Answered in Global C-Reactive Protein Testing Market Report:

  • What is the sales/revenue generated by C-Reactive Protein Testing across all regions during the forecast period?
  • What are the opportunities in the global C-Reactive Protein Testing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

C-Reactive Protein Testing Market - Research Objectives and Research Approach

The comprehensive report on the global C-Reactive Protein Testing Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global C-Reactive Protein Testing Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global C-Reactive Protein Testing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global C-reactive Protein Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global C-reactive Protein Testing Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Overview of C-reactive Protein Testing Market
  • 5.2. Key Product/ Brand Analysis
  • 5.3. Pipeline Analysis
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global C-reactive Protein Testing Market Analysis and Forecast, by Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Test Type, 2017-2031
    • 6.3.1. Standard C-reactive Protein Test
    • 6.3.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 6.4. Market Attractiveness Analysis, by Test Type

7. Global C-reactive Protein Testing Market Analysis and Forecast, by Type of Assay

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 7.3.1. ELISA
    • 7.3.2. Immunoturbidimetry
    • 7.3.3. Immuno-chromatography
    • 7.3.4. Immunofluorescence
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Type of Assay

8. Global C-reactive Protein Testing Market Analysis and Forecasts, by Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Indication, 2017-2031
    • 8.3.1. Heart Diseases
    • 8.3.2. Inflammatory Diseases
    • 8.3.3. Infectious Diseases
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Indication

9. Global C-reactive Protein Testing Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospital Associated Laboratories
    • 9.3.2. Independent Diagnostic Laboratories
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global C-reactive Protein Testing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America C-reactive Protein Testing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Test Type, 2017-2031
    • 11.2.1. Standard C-reactive Protein Test
    • 11.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 11.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 11.3.1. ELISA
    • 11.3.2. Immunoturbidimetry
    • 11.3.3. Immuno-chromatography
    • 11.3.4. Immunofluorescence
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Indication, 2017-2031
    • 11.4.1. Heart Diseases
    • 11.4.2. Inflammatory Diseases
    • 11.4.3. Infectious Diseases
    • 11.4.4. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospital Associated Laboratories
    • 11.5.2. Independent Diagnostic Laboratories
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Test Type
    • 11.7.2. By Type of Assay
    • 11.7.3. By Indication
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe C-reactive Protein Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Test Type, 2017-2031
    • 12.2.1. Standard C-reactive Protein Test
    • 12.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 12.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 12.3.1. ELISA
    • 12.3.2. Immunoturbidimetry
    • 12.3.3. Immuno-chromatography
    • 12.3.4. Immunofluorescence
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Indication, 2017-2031
    • 12.4.1. Heart Diseases
    • 12.4.2. Inflammatory Diseases
    • 12.4.3. Infectious Diseases
    • 12.4.4. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospital Associated Laboratories
    • 12.5.2. Independent Diagnostic Laboratories
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Test Type
    • 12.7.2. By Type of Assay
    • 12.7.3. By Indication
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific C-reactive Protein Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Test Type, 2017-2031
    • 13.2.1. Standard C-reactive Protein Test
    • 13.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 13.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 13.3.1. ELISA
    • 13.3.2. Immunoturbidimetry
    • 13.3.3. Immuno-chromatography
    • 13.3.4. Immunofluorescence
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Indication, 2017-2031
    • 13.4.1. Heart Diseases
    • 13.4.2. Inflammatory Diseases
    • 13.4.3. Infectious Diseases
    • 13.4.4. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospital Associated Laboratories
    • 13.5.2. Independent Diagnostic Laboratories
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Test Type
    • 13.7.2. By Type of Assay
    • 13.7.3. By Indication
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America C-reactive Protein Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Test Type, 2017-2031
    • 14.2.1. Standard C-reactive Protein Test
    • 14.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 14.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 14.3.1. ELISA
    • 14.3.2. Immunoturbidimetry
    • 14.3.3. Immuno-chromatography
    • 14.3.4. Immunofluorescence
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Indication, 2017-2031
    • 14.4.1. Heart Diseases
    • 14.4.2. Inflammatory Diseases
    • 14.4.3. Infectious Diseases
    • 14.4.4. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospital Associated Laboratories
    • 14.5.2. Independent Diagnostic Laboratories
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Test Type
    • 14.7.2. By Type of Assay
    • 14.7.3. By Indication
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa C-reactive Protein Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Test Type, 2017-2031
    • 15.2.1. Standard C-reactive Protein Test
    • 15.2.2. High-sensitivity C-reactive Protein (hs-CRP) Test
  • 15.3. Market Value Forecast, by Type of Assay, 2017-2031
    • 15.3.1. ELISA
    • 15.3.2. Immunoturbidimetry
    • 15.3.3. Immuno-chromatography
    • 15.3.4. Immunofluorescence
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by Indication, 2017-2031
    • 15.4.1. Heart Diseases
    • 15.4.2. Inflammatory Diseases
    • 15.4.3. Infectious Diseases
    • 15.4.4. Others
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospital Associated Laboratories
    • 15.5.2. Independent Diagnostic Laboratories
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Test Type
    • 15.7.2. By Type of Assay
    • 15.7.3. By Indication
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Agilent Technologies, Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Laboratory Corporation of America Holdings
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Thermo Fisher Scientific
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Abbott Laboratories
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. F. Hoffmann-La Roche Ltd.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Creative Diagnostics
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. DxGen Corp
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. CTK Biotech, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Getein Biotech, Inc.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Goldsite Diagnostics, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. OptiBio Co., Ltd.
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. Nanjing Vazyme Biotech Co., Ltd.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview

List of Tables

  • Table 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 02: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 03: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 04: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 08: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 09: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 10: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 13: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 14: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 15: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 18: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 19: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 20: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 23: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 24: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 25: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 28: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Type of Assay, 2017-2031
  • Table 29: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by Indication, 2017-2031
  • Table 30: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global C-reactive Protein Testing Market Value Share, by Test Type, 2022
  • Figure 03: Global C-reactive Protein Testing Market Value Share, by Types of Assay, 2022
  • Figure 04: Global C-reactive Protein Testing Market Value Share, by Indication, 2022
  • Figure 05: Global C-reactive Protein Testing Market Value Share, by End-user, 2022
  • Figure 06: Global C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 07: Global C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 08: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Standard C-reactive Protein Test , 2017-2031
  • Figure 09: Global C-reactive Protein Testing Market Revenue (US$ Mn), by High-sensitivity C-reactive Protein (hs-CRP) Test, 2017-2031
  • Figure 10: Global C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 11: Global C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 12: Global C-reactive Protein Testing Market Value (US$ Mn), by ELISA, 2017-2031
  • Figure 13: Global C-reactive Protein Testing Market Value (US$ Mn), by Immunoturbidimetry, 2017-2031
  • Figure 14: Global C-reactive Protein Testing Market Value (US$ Mn), by Irreversible Immuno-chromatography, 2017-2031
  • Figure 15: Global C-reactive Protein Testing Market Value (US$ Mn), by Immunofluorescence, 2017-2031
  • Figure 16: Global C-reactive Protein Testing Market Value (US$ Mn), by Others, 2017-2031
  • Figure 17: Global C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 18: Global C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 19: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Heart Diseases, 2017-2031
  • Figure 20: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Inflammatory Diseases, 2017-2031
  • Figure 21: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Infectious Diseases, 2017-2031
  • Figure 22: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 23: Global C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 24: Global C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 25: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Hospital Associated Laboratories, 2017-2031
  • Figure 26: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Independent Diagnostic Laboratories, 2017-2031
  • Figure 27: Global C-reactive Protein Testing Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 28: Global C-reactive Protein Testing Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 29: Global C-reactive Protein Testing Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 30: North America C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 31: North America C-reactive Protein Testing Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 32: North America C-reactive Protein Testing Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 33: North America C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 34: North America C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 35: North America C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 36: North America C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 37: North America C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 38: North America C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 39: North America C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: North America C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Europe C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 42: Europe C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 43: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Europe C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 45: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 46: Europe C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 47: Europe C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 48: Europe C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 49: Europe C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 50: Europe C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 51: Europe C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 52: Asia Pacific C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 53: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 56: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 57: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 58: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 59: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 60: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 61: Asia Pacific C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 62: Asia Pacific C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 63: Latin America C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 64: Latin America C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 65: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 66: Latin America C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 67: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 68: Latin America C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 69: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay, 2023-2031
  • Figure 70: Latin America C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 71: Latin America C-reactive Protein Testing Market Attractiveness Analysis, Indication, 2023-2031
  • Figure 72: Latin America C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 73: Latin America C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 74: Middle East & Africa C-reactive Protein Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 75: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 76: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 77: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Test Type, 2022 and 2031
  • Figure 78: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Test Type, 2023-2031
  • Figure 79: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Type of Assay, 2022 and 2031
  • Figure 80: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Type of Assay 2023-2031
  • Figure 81: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by Indication, 2022 and 2031
  • Figure 82: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by Indication, 2023-2031
  • Figure 83: Middle East & Africa C-reactive Protein Testing Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 84: Middle East & Africa C-reactive Protein Testing Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 85: Global C-reactive Protein Testing Market Share Analysis By Company (2022)